Natera (NTRA) Non-Current Debt (2014 - 2024)
Natera's (NTRA) quarterly Non-Current Debt came in at $286.5 million in Q3 2024, up 1.39% on a YoY basis from $282.6 million in Q4 2023, and up 1.04% quarter-over-quarter from $283.6 million in Q2 2024.
Analysis
Natera (NTRA) Non-Current Debt (2014 - 2024) Analysis & Trends
Natera (NTRA) has reported Non-Current Debt for 10 consecutive years, with $286.5 million the latest figure, recorded in Q3 2024.
- For the quarter ending Q3 2024, Non-Current Debt rose 1.39% year-over-year to $286.5 million; the trailing twelve-month figure through Sep 2024 stood at $286.5 million (up 1.39% YoY), and the FY2023 full-year result was $282.9 million, changed 0.46% from the prior year.
- Non-Current Debt advanced to $286.5 million in Q3 2024 per NTRA's latest filing, from $283.6 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $286.5 million in Q3 2024 and bottomed at $72.9 million in Q1 2020.
- Historically, Non-Current Debt has averaged $257.9 million across 5 years, with a median of $281.0 million in 2022.
- The sharpest annual moves came in 2020 and 2021: Non-Current Debt decreased 0.75% in 2020, then jumped 283.46% in 2021.
- Over 5 years, Non-Current Debt stood at $202.5 million in 2020, then surged by 38.47% to $280.4 million in 2021, then grew by 0.45% to $281.7 million in 2022, then advanced by 0.46% to $282.9 million in 2023, then gained by 1.27% to $286.5 million in 2024.
- According to Business Quant data, Non-Current Debt over the past three periods registered $286.5 million, $283.6 million, and $283.3 million for Q3 2024, Q2 2024, and Q1 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | - |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | 5.64 Bn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | 5.86 Bn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | - |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | - |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | 392.97 Mn |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | 2.14 Bn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | 91.03 Mn |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | - |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 286.55 Mn |
| Jun 30, 2024 | 283.60 Mn |
| Mar 31, 2024 | 283.27 Mn |
| Dec 31, 2023 | 282.95 Mn |
| Sep 30, 2023 | 282.62 Mn |
| Jun 30, 2023 | 282.30 Mn |
| Mar 31, 2023 | 281.97 Mn |
| Dec 31, 2022 | 281.65 Mn |
| Sep 30, 2022 | 281.34 Mn |
| Jun 30, 2022 | 281.02 Mn |
| Mar 31, 2022 | 280.71 Mn |
| Dec 31, 2021 | 280.39 Mn |
| Sep 30, 2021 | 280.09 Mn |
| Jun 30, 2021 | 279.78 Mn |
| Mar 31, 2021 | 279.47 Mn |
| Dec 31, 2020 | 202.49 Mn |
| Sep 30, 2020 | 199.96 Mn |
| Jun 30, 2020 | 197.48 Mn |
| Mar 31, 2020 | 72.88 Mn |
| Dec 31, 2019 | 73.66 Mn |